Ask the Expert

The Personalized Medicine Foundation’s Ask The Expert series offers cancer patients the opportunity to ask leading cancer care providers questions.

Submit Your question about liver cancer here

Ask the Expert About Lung Cancer and COVID-19 Submit your question about lung cancer and COVID-19 to Charu Aggarwal, MD, MPH, Perelman School of Medicine, University of Pennsylvia

Papillary Thyroid Cancer Diagnosis and Treatment Planning Julie Ann Sosa, MD, Duke University, answer your questions about papillary thyroid cancer.

Ask the Expert about Lynch Syndrome Kimberly Perez, MD, Dana-Farber Cancer Institute, answers questions about hereditary colon cancer including genetic testing and cancer screening.

Ask the Expert: Advanced Colon Cancer Tanios Bekaii-Saab, MD, Head-Mayo Clinic Gastrointestinal Cancer Program & Director of Cancer Clinical Research answers key questions on the role of precision cancer medicine for the treatment of Colon Cancer.

Ask The Expert About Back Pain, Arthritis and Inflammatory Conditions David G Borenstein, MD, answers questions about back pain, ankylosing spondylitis and inflammatory conditions of the spine.

Ask the Expert About Cancer, Diet and Exercise Jennifer Ligibel, MD, of The Susan F Smith Center for Women’s Cancers, Dana-Farber Cancer Institute, answers questions about the role of diet and exercise in the management of cancer.

Questions Patients Should Ask Their Doctor When Determining Cancer Treatment C.H. Weaver, MD, explains how to approach a diagnosis of cancer and the key questions to ask to determine the best treatment.

Diagnosed With Cancer? When to Get a Second Opinion? Seek, Listen, Learn C.H. Weaver, MD, Managing Editor and Founder of The Personalized Medicine Foundation explains who should get a second opinion following a cancer diagnosis.

Precision Cancer Medicines – Changing Cancer Care for the Better Precision cancer medicine is an evolving concept in cancer care that aims to leverage new genomic information about a specific cancer to more precisely target treatment. It’s a rapidly evolving area that is changing cancer care and patients need to understand its role in the management of their cancer.

Advances in the Management of Myeloproliferative Neoplasms Myeloproliferative neoplasm (MPN) expert, Ruben A. Mesa, MD, Director, UT Health San Antonio Cancer Center answered questions about MPN, including polycythemia vera (PV), essential thrombocythemia (ET) and myelofibrosis (MF).

CRISPR: Taking Us to a New Frontier CRISPR which stands for clustered regularly interspaced short palindromic repeats represents a new gene-editing technique which will change the way cancer is treated.


Dealing with a new diagnosis or recurrence? Cancer First Call is for you.


%d bloggers like this: